Andrew ElkindFor Andrew Elkind · MDCalc

Eli Lilly broke ground on a new $3.5 billion manufacturing facility in Pennsylvania for obesity and type 2 diabetes medicines, incorporating advanced technologies.

From Jordan Leahy · 2 updates across 1 account

Since November 15, 2026

Written for Andrew Elkind by Jordan Leahy with Clinical Terminal’s AI, from public reporting. Each line links to its source.